Henriette Uhlenhaut studied Biotechnology at the Technical University of Braunschweig, Germany, and Applied Biology at Georgia Tech in Atlanta, USA. She graduated with a PhD from the EMBL University of Heidelberg international graduate program in 2007. During that time, she became interested in mechanisms of transcriptional repression important for mammalian homeostasis. That is why nuclear receptors became the focus of her postdoc in the Evans Lab at the Salk Institute in La Jolla, USA and at the Max Delbrueck Center for Molecular Medicine in Berlin.
Since 2013, Prof. Uhlenhaut is a PI at the Helmholtz Diabetes Center in Munich, Germany. She received funding from the DFG Emmy Noether Program and the ERC Starting Grant. From 2018-2019 she was also a professor at the LMU Gene Center. Since 2019, she holds the Chair for Metabolic Programming at the TUM School of Life Sciences. Her contributions to endocrine research have been honored with the Friedmund Neumann Award and the Heinz Maier Leibnitz Prize.